You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (35)

Journals (0)

1-10 of 35 results for trastuzumab cost

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Evaluation of cost and infusion-related reactions among intravenous trastuzumab,subcutaneous trastuzumab,and trastuzumab biosimilars at an academic medical center

Retricted access

Research article

First published 2025-4

Evaluation of cost and infusion-related reactions among intravenous trastuzumab,subcutaneous trastuzumab,and trastuzumab biosimilars at an academic medical center

Daijah M Davis, Kasey Jackson, Christina Hoppe

Journal of Oncology Pharmacy Practice

Select article: Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore

Open access

Brief report

First published 2026

Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore

Yanting Ouyang, Yi Ting Ng, Wei Wei Hong [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review

Retricted access

Research article

First published 2009-2

Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review

Agnes LF Chan, Henry WC Leung, Chin-Li Lu [...]

Annals of Pharmacotherapy

Select article: First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: Cost-minimization analysis

Retricted access

Research article

First published 2014-10

First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: Cost-minimization analysis

Virginie Nerich, Jennifer Chelly, Philippe Montcuquet [...]

Journal of Oncology Pharmacy Practice

Select article: Cost-effectiveness of sequential treatment strategies involving first-line pembrolizumab with trastuzumab and chemotherapy for unresectable metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma

Open access

Research article

First published 2025

Cost-effectiveness of sequential treatment strategies involving first-line pembrolizumab with trastuzumab and chemotherapy for unresectable metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma

Caicong You, Jiahao Zhang, Jianying Lei [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancer

Open access

Research article

First published 2023

Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancer

Jiangping Yang, Jiaqi Han, Ni Zeng [...]

Therapeutic Advances in Medical Oncology

Select article: Cost-minimization analysis comparing subcutaneous trastuzumab at home with intravenous trastuzumab for HER2-positive breast cancer in Singapore

Open access

Research article

First published 2024

Cost-minimization analysis comparing subcutaneous trastuzumab at home with intravenous trastuzumab for HER2-positive breast cancer in Singapore

Yanting Ouyang, Han Yi Lee, Fun Loon Leong [...]

Therapeutic Advances in Medical Oncology

Select article: RETRACTED: Cost-utility analysis of trastuzumab combined with Docetaxel for patients with HER-2 positive metastatic breast cancer – real world claim data

Retricted access

Research article

First published 2018-9

RETRACTED: Cost-utility analysis of trastuzumab combined with Docetaxel for patients with HER-2 positive metastatic breast cancer – real world claim data

Henry WC Leung, Agnes LF Chan, Shyh-Yau Wang

Journal of Oncology Pharmacy Practice

Select article: Trastuzumab/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer

Retricted access

Review article

First published 2020-3

Trastuzumab/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer

Marissa R. Duco, Joshua L. Murdock, David J. Reeves

Annals of Pharmacotherapy

Select article: Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Open access

Review article

First published 2012

Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Alwin Jeyakumar, Tallal Younis

Clinical Medicine Insights: Oncology

1
2
3
4
10 / page

Article type

Publication date

Subjects

Access